EUVIMEDEUVIMED entdecken
Crossref

Pharmacological actions of Azadirachta indica leaf ethanolic extract: A multi-platform approach for standardization and assessment of therapeutic potential

Md. Islam, Md. Hoque, Md. Alam, Saiful Islam

Journal of Advanced Biotechnology and Experimental Therapeutics · 2026 · 9 (2) · 264

DOI: 10.5455/jabet.2026.20 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Advanced Biotechnology and Experimental Therapeutics, 2026. Verfasst von Md. Islam und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Azadirachta indica A. Juss. (neem) leaf ethanolic extract was characterized using multi-platform analytical and bioinformatics approaches to establish its phytochemical and pharmacological profile. Soxhlet extraction with 98% ethanol yielded 10.0 ± 0.5% (w/w) dark green viscous extract. Comprehensive analysis employed Thin-Layer Chromatography (TLC), High-Performance Liquid Chromatography with Diode-Array Detection (HPLC-DAD), Gas Chromatography-Mass Spectrometry (GC-MS), and Nuclear Magnetic Resonance (NMR) spectroscopy. Bioinformatics included PASS prediction, SwissTargetPrediction, MetaboAnalyst 5.0 pathway enrichment, and Cytoscape network construction. TLC revealed optimal separation using hexane:ethyl acetate:acetic acid (50:49:1) with 4-5 distinct bands. HPLC-DAD confirmed azadirachtin (Rt = 7.51 min) and identified additional limonoids including salannin and gedunin. GC-MS identified 30 compounds, with chlorinated terpenoid ester (36.41%), polycyclic terpenoid acetate (21.60%), and 2,4-di-tert-butylphenol (21.17%) as major constituents. NMR provided structural confirmation for limonoids, flavonoids, and fatty acid derivatives. The extract demonstrated significant antimicrobial activity against Staphylococcus aureus (15.3 ± 0.6 mm) and Escherichia coli (12.7 ± 0.5 mm), correlating with 2, 4-di-tert-butylphenol and was complemented by gedunin despite its minimal concentration. Bioinformatics predicted insecticidal (Pa = 0.845), antimicrobial (Pa = 0.912), anti-inflammatory (Pa = 0.789), and antioxidant (Pa = 0.802) activities for key compounds. Pathway enrichment identified terpenoid backbone biosynthesis (p = 3.2×10⁻⁶), steroid biosynthesis (p = 1.8×10⁻⁵), and NF-κB signaling (p = 4.5×10⁻⁴) as significantly enriched pathways. Network pharmacology demonstrated multi-target interactions involving ecdysone receptor, NF-κB, COX-2, and antioxidant enzymes. This integrated approach provides validated protocol for neem standardization and mechanistic insights into its polypharmacological effects.

Zitieren

APA

Islam, M., Hoque, M., Alam, M., & Islam, S. (2026). Pharmacological actions of Azadirachta indica leaf ethanolic extract: A multi-platform approach for standardization and assessment of therapeutic potential. Journal of Advanced Biotechnology and Experimental Therapeutics, 9(2), 264. https://doi.org/10.5455/jabet.2026.20

Vancouver

Islam M, Hoque M, Alam M, Islam S. Pharmacological actions of Azadirachta indica leaf ethanolic extract: A multi-platform approach for standardization and assessment of therapeutic potential. Journal of Advanced Biotechnology and Experimental Therapeutics. 2026;9(2):264. doi:10.5455/jabet.2026.20

BibTeX
@article{Islam2026,
  author = {Islam, Md. and Hoque, Md. and Alam, Md. and Islam, Saiful},
  title = {Pharmacological actions of Azadirachta indica leaf ethanolic extract: A multi-platform approach for standardization and assessment of therapeutic potential},
  journal = {Journal of Advanced Biotechnology and Experimental Therapeutics},
  year = {2026},
  volume = {9},
  number = {2},
  pages = {264},
  doi = {10.5455/jabet.2026.20}
}
Kostenlos starten →